Depyrogenated Sterile Empty Vials Market Overview
As per MRFR analysis, the Depyrogenated Sterile Empty Vials Market Size was estimated at 3.05 (USD Billion) in 2022. The Depyrogenated Sterile Empty Vials Market Industry is expected to grow from 3.18(USD Billion) in 2023 to 4.6 (USD Billion) by 2032. The Depyrogenated Sterile Empty Vials Market CAGR (growth rate) is expected to be around 4.18% during the forecast period (2024 - 2032).
Key Depyrogenated Sterile Empty Vials Market Trends Highlighted
The demand for Depyrogenated Sterile Empty Vials is expected to expand rapidly due to the escalating requirement for vaccines and biologics. The increasing penetration of single-use technologies in the biopharmaceutical sector is also contributing to this increase. Depyrogenated sterile empty vials are used to prevent contamination and preserve the delivery of the vaccine or biological product to humans on time.
Factors such as the growing prevalence of chronic and severe diseases and more immunization programs undertaken across the globe are some of the pull factors propellent depyrogenated sterile empty vials market. Similarly, the adoption of innovative manufacturing processes as well as there is a strong emphasis on the creation of new drug delivery methods creating opportunities for market players.
Current barriers to market entry comprise tamper-evident seals which are wrapped around the neck of vials and the growing utilization of pharmacopoeial standards which describe the legal requirements of medicines. Alongside the increasing demand for prefilled vials for injectables and a growing preference for automated vial filling systems are also determining the market progression.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Depyrogenated Sterile Empty Vials Market Drivers
Increasing Demand for Injectable Drugs
The market for depyrogenated sterile empty vials is primarily being driven by the increasing demand for injectable drugs. Such drugs are used for treatment of an extensive number of diseases and medical conditions including cancer, type 2 diabetes, and autoimmune diseases. This is primarily because of the increase in development of chronic diseases as more and more consumers are becoming more susceptible given their lifestyle habits.Additionally, consumers are adopting more biologically based drugs in search for permanent cures to such diseases. Such medical drugs need to be clean, with the only way to achieve this being depyrogenated sterile empty vials. It can, therefore, be expected that the market for such vials will only continue growing as more consumers embrace injectable drugs.
Technological Advancements in Vial Manufacturing
Another significant driver driving the expansion of the Depyrogenated Sterile Empty Vials Market Industry is technological advancements in vial manufacturing. These advancements have resulted in the production of vials with enhanced barrier properties, reduced breakage rates, and increased compatibility of automated filling systems. The depyrogenated sterile empty vials market has benefited from the adoption of new technologies, such as blow-fill-seal (BFS) technology.BFS technology enables vial production with higher precision and efficiency, which, in turn, translates into lower production costs and enhanced product quality.
Rising Healthcare Expenditure
Rising healthcare expenditure is another key factor driving the growth of the Depyrogenated Sterile Empty Vials Market Industry. Governments and private healthcare providers are spending more on healthcare, leading to more demand for medical devices and supplies, including depyrogenated sterile empty vials. In addition, the prevalence of chronic diseases and the aging population are both increasing, causing the healthcare expenditure to rise as well.
Depyrogenated Sterile Empty Vials Market Segment Insights
Depyrogenated Sterile Empty Vials Market Material Type Insights
01 Executive Summary 02 Market Introduction The choice of material for Depyrogenated Sterile Empty Vials depends on the type of drug or biologic with which it will be used. The market for Depyrogenated Sterile Empty Vials is segmented by Material Type into Glass, Plastic, and Other Materials. Glass is the most common material used for Depyrogenated Sterile Empty Vials, as it is chemically inert, and suitable for compatibility with any drug or biologic. It is resistant to thermal stress, easy to sterilize and depyrogenate, and smooth inner surfaces that prevent the development of bio films.Furthermore, glass is environmentally friendly, as it is 100% recyclable. The Depyrogenated Sterile Empty Vials Market for Glass is estimated to reach USD 2.3 billion by 2024, growing at a CAGR of 4.5%.
Plastic is another common material used for Depyrogenated Sterile Empty Vials. The lower cost of plain vial materials made of plastic is a significant factor driving their adoption. Additionally, plastic vials are more flexible and lighter weight, which is more ideal for shipping. Furthermore, plastic material does not crack or break during impact like glass material.The disadvantages of plastic materials are that they can be permeable to gases and are difficult to depyrogenate. The Depyrogenated Sterile Empty Vials Market for Plastic is estimated to reach USD 1.5 billion by 2024, growing at a CAGR of 5.1%. Other Materials, including polypropylene and cyclo olefin copolymer, are also used for Depyrogenated Sterile Empty Vials. These materials have various material advantages. For example, polypropylene vials are lightweight, durable, and chemical resistant. Cyclo olefin copolymer vials offer a high degree of clarity and gas barrier properties.The Depyrogenated Sterile Empty Vials Market for Other Materials is estimated to reach USD 0.3 billion by 2024, growing at a CAGR of 6.2%.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Depyrogenated Sterile Empty Vials Market Capacity Insights
The Depyrogenated Sterile Empty Vials Market is segmented by Capacity into less than 10mL, 10-20mL, 20-30mL and greater than 30mL. Among these, the 10-20mL capacity segment dominated the Depyrogenated Sterile Empty Vials Market by holding the highest market share in 2023. The 10-20mL vial encompassed approximately 36.5% of the Depyrogenated Sterile Empty Vials Market revenue. This is because the 10-20mL vials are widely used for packaging injectables, vaccines and other pharmaceutical products. However, less than 10mL capacity segment is expected to record the highest growth rate during the forecast period.This is due to the rising demand for vials smaller than 10mL capacity to package ophthalmic and other speciality drugs. In the case of 20-30mL and greater than 30mL, both the segments are expected to grow at a moderate rate as the demand for these vials is increasing to store bulk pharmaceutical products and biologics.
Depyrogenated Sterile Empty Vials Market Closure Type Insights
The Depyrogenated Sterile Empty Vials Market is segmented based on Closure Type into Rubber Stopper, Flip-Off Caps, Screw Caps, and Crimp Caps. The Rubber Stopper segment is projected to hold a significant market share over the forecast period owing to its wide usage in pharmaceutical packaging due to its ability to maintain sterility and prevent contamination. The Flip-Off Caps segment is expected to witness substantial growth due to its ease of use and cost-effectiveness. The growth of the Screw Caps segment is attributed to its secure sealing capabilities and compatibility with automated filling lines.The Crimp Caps segment is projected to gain traction due to its secure and tamper-evident closure, making it suitable for high-value pharmaceuticals. These insights are crucial for market players to strategize and cater to the evolving needs of the healthcare industry.
Depyrogenated Sterile Empty Vials Market Sterilization Method Insights
Autoclaving held the largest revenue share of over 35.6% in 2023 with a market value of approximately 1.14 billion USD. This method is widely used for sterilization of depyrogenated sterile empty vials due to its effectiveness in eliminating microorganisms. The widespread adoption of autoclaving in pharmaceutical and healthcare settings contributes to its dominance in the market. Dry Heat Sterilization is projected to exhibit a steady growth rate during the forecast period, owing to its ability to sterilize vials without the use of moisture. This method is particularly suitable for heat-resistant materials and offers advantages such as low operating costs and reduced cycle times.E-beam Radiation is gaining traction as a sterilization method, owing to its high efficiency and ability to penetrate materials deeply. The increasing use of E-beam radiation in pharmaceutical manufacturing is expected to drive the growth of this segment in the coming years. Gamma Radiation is another widely used sterilization method, particularly for high-volume production of depyrogenated sterile empty vials. This method utilizes ionizing radiation to eliminate microorganisms and is known for its reliability and effectiveness.
Depyrogenated Sterile Empty Vials Market End-Use Application Insights
The Depyrogenated Sterile Empty Vials Market is segmented by end-use application into pharmaceuticals, biotechnology, diagnostics, and research and development. Among these segments, the pharmaceuticals segment held the largest market share in 2023, and it is expected to continue its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing demand for injectable drugs and vaccines. The biotechnology segment is expected to witness significant growth during the forecast period due to the rising demand for biologics and the increasing adoption of cell-based therapies.The diagnostics segment is also expected to grow at a steady pace during the forecast period, driven by the increasing demand for rapid and accurate diagnostic tests. The research and development segment is expected to exhibit moderate growth during the forecast period, supported by the rising investments in drug discovery and development.
Depyrogenated Sterile Empty Vials Market Regional Insights
The regional segmentation of the Depyrogenated Sterile Empty Vials Market offers valuable insights into the diverse market dynamics across different regions. North America holds a significant share of the market, driven by the presence of major pharmaceutical and biotechnology companies, stringent regulatory frameworks, and advanced healthcare infrastructure. Europe follows closely, with a robust healthcare system and a large population base. The APAC region is projected to witness substantial growth in the coming years, owing to the rising demand for sterile vials in emerging economies like China and India.South America and MEA also represent promising markets for Depyrogenated Sterile Empty Vials, with growing healthcare investments and increasing demand for high-quality medical supplies.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Depyrogenated Sterile Empty Vials Market Key Players and Competitive Insights
The leading Depyrogenated Sterile Empty Vials Market players are focused to expand their footprints through partnerships, acquisitions, and joint ventures. In addition to this, significant players are investing in research and development to develop their product offerings and cater to the growing demands of the pharmaceutical and biotechnology industry. Industry players are facing an increasing intensity in the Depyrogenated Sterile Empty Vials Market with the growing number of startups trying to capture a market share in the industry. Moreover, the Depyrogenated Sterile Empty Vials Market is positively developing on the back of reviving demand for high-quality vials in pharmaceutical, biopharmaceutical, and research uses. The market is also benefiting from the expanding adoption of advanced manufacturing processes and technologies.
SCHOTT AG is one of the top players in the Depyrogenated Sterile Empty Vials Market to provide high-quality vials meeting the stringent requirements of the pharmaceutical industry. The company, serving its products for a broad range of drugs and biologics developments, offers glass, plastic, and depyrogenated vials among its product portfolios. SCHOTT AG flagship company is committed to providing vials of the highest quality, which are matched with high investments in R&D. On the other hand, Corning Incorporated is among the key competitors in the Depyrogenated Sterile Empty Vials Market. The vials are known for high quality, durability, and reliability. The company serves the pharmaceutical and biotechnology industry with its range of sterile vials, depyrogenated vials, and custom vials. Moreover, Corning Incorporated has a significant market presence worldwide.
Key Companies in the Depyrogenated Sterile Empty Vials Market Include
Depyrogenated Sterile Empty Vials Market Industry Developments
The depyrogenated sterile empty vials market size was valued at USD 3.18 billion in 2023 and is projected to grow to USD 4.6 billion by 2032, exhibiting a CAGR of 4.18% during the forecast period. The increasing demand for injectable drugs, rising prevalence of chronic diseases, and growing adoption of biologics are key factors driving the market growth. Moreover, government initiatives to promote vaccination and immunization programs are further propelling the demand for depyrogenated sterile empty vials.Recent news developments in the market include the launch of new products by key players, such as Schott's EZ-Fill vials designed for high-speed filling lines. Additionally, there is a growing focus on sustainability, with manufacturers investing in eco-friendly vial production processes. The market is expected to witness continued growth in the coming years, driven by the aforementioned factors and technological advancements.
Depyrogenated Sterile Empty Vials Market Segmentation Insights
Depyrogenated Sterile Empty Vials Market Material Type Outlook
- Glass
- Plastic
- Other Materials (e.g., Polypropylene, Cyclo Olefin Copolymer)
Depyrogenated Sterile Empty Vials Market Capacity Outlook
- Less than 10mL
-
- 10-20mL
-
- 20-30mL
-
- Greater than 30mL
Depyrogenated Sterile Empty Vials Market Closure Type Outlook
- Rubber Stopper
-
- Flip-Off Caps
-
- Screw Caps
-
- Crimp Caps
Depyrogenated Sterile Empty Vials Market Sterilization Method Outlook
- Autoclaving
-
- Dry Heat Sterilization
-
- E-beam Radiation
-
- Gamma Radiation
Depyrogenated Sterile Empty Vials Market End-Use Application Outlook
- Pharmaceuticals
-
- Biotechnology
-
- Diagnostics
-
- Research and Development
Depyrogenated Sterile Empty Vials Market Regional Outlook
- North America
-
- Europe
-
- South America
-
- Asia Pacific
-
- Middle East and Africa
Report Attribute/Metric
|
Details
|
Market Size 2022
|
3.05(USD Billion)
|
Market Size 2023
|
3.18(USD Billion)
|
Market Size 2032
|
4.6(USD Billion)
|
Compound Annual Growth Rate (CAGR)
|
4.18% (2024 - 2032)
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
Base Year
|
2023
|
Market Forecast Period
|
2024 - 2032
|
Historical Data
|
2019 - 2023
|
Market Forecast Units
|
USD Billion
|
Key Companies Profiled
|
Histopack, Ypsomed, SGD Pharma, Gerresheimer, Lonza Group, Wheaton Industries, Piramal Glass, Daikyo Seiko, Becton, Dickinson and Company, Corning, Nipro Corporation, Stevanato Group, Ravin Ganpati Group, Thermo Fisher Scientific, Schott
|
Segments Covered
|
Material Type, Capacity, Closure Type, Sterilization Method, End-Use Application, Regional
|
Key Market Opportunities
|
Growing demand for injectable drugs Increasing prevalence of chronic diseases Technological advancements in vial manufacturing Rising healthcare expenditure in emerging economies Expansion of biopharmaceutical industry
|
Key Market Dynamics
|
Increasing demand Technological advancements Growth in pharmaceutical industry Rising healthcare expenditure Expanding applications
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Frequently Asked Questions (FAQ) :
The Depyrogenated Sterile Empty Vials Market is anticipated to reach a valuation of USD 3.18 billion in 2023.
The Depyrogenated Sterile Empty Vials Market is estimated to register a CAGR of 4.18% from 2023 to 2032.
North America is projected to dominate the Depyrogenated Sterile Empty Vials Market in 2023.
The pharmaceutical packaging segment is expected to drive the growth of the Depyrogenated Sterile Empty Vials Market.
Key competitors in the Depyrogenated Sterile Empty Vials Market include Schott AG, Corning Incorporated, and SGD Pharma.
Growing demand for injectable drugs and increasing focus on patient safety are key factors driving the growth of the Depyrogenated Sterile Empty Vials Market.
Stringent regulatory requirements and intense competition are key challenges faced by the Depyrogenated Sterile Empty Vials Market.
Advancements in manufacturing technology and increasing the adoption of automation are key trends shaping the Depyrogenated Sterile Empty Vials Market.
The Depyrogenated Sterile Empty Vials Market is projected to reach a valuation of USD 4.6 billion by 2032.
Asia-Pacific is expected to witness the highest growth rate in the Depyrogenated Sterile Empty Vials Market during 2023-2032.